MarketWell CEO Doug Lynch on Natural GLP-1 Support at SupplySide Global 2025
MarketWell Nutrition is proud to share that our CEO and Founder, Doug Lynch, was quoted in a recent Nutritional Outlook article highlighting the dominance of GLP-1-related innovations at SupplySide Global 2025.
The article, "GLP-1 Support Takes Over SupplySide Global 2025", explores how ingredient suppliers are addressing the explosive growth of GLP-1 receptor agonist medications (like Ozempic and Wegovy) through both companion support products and natural alternatives that boost the body's own GLP-1 production. Doug Lynch, speaking on the potential of citrus flavonoid ingredient Eriomin from Ingredients by Nature (where he serves as Commercial Lead), emphasized the importance of safe, natural options for consumers transitioning off pharmaceutical GLP-1 therapies:“There are a lot of consumers that are on drugs for GLP-1 boosting; at some point they have to get off,” says Lynch. “What happens is, if you're on an injectable product, you lose your weight, and you lose your fat, but you also lose muscle. The challenge here is that when you come off these drugs, the fat comes back. So, there has to be an alternative to those for people that want to have a soft landing when they come off those medications.”
He also discussed how natural ingredients like Eriomin can complement early interventions, such as metformin use in prediabetic individuals, providing a proactive approach to metabolic health without relying solely on pharmaceuticals.
At MarketWell Nutrition, we see this trend as a pivotal opportunity for the supplement industry to deliver evidence-based, consumer-friendly solutions that support sustainable weight management, muscle preservation, and overall metabolic wellness. As leaders in commercialization strategy for clinical nutrition and dietary supplements, we're excited to guide brands through this evolving landscape—whether developing GLP-1 companion products, natural secretion boosters, or "off-ramp" formulations for long-term success. Read the full article here to see how GLP-1 support is reshaping the future of nutrition.
